LEADER 04519nam 22006495 450 001 9910253867703321 005 20200706195730.0 010 $a981-10-0989-9 024 7 $a10.1007/978-981-10-0989-1 035 $a(CKB)3710000000717863 035 $a(DE-He213)978-981-10-0989-1 035 $a(MiAaPQ)EBC4533826 035 $a(PPN)194075710 035 $a(EXLCZ)993710000000717863 100 $a20160527d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPerspectives in Translational Research in Life Sciences and Biomedicine $eTranslational Outcomes Research in Life Sciences and Translational Medicine, Volume 1 /$fby Ena Ray Banerjee 205 $a1st ed. 2016. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2016. 215 $a1 online resource (XII, 270 p. 169 illus., 148 illus. in color.) 311 $a981-10-0988-0 320 $aIncludes bibliographical references at the end of each chapters. 327 $aChapter 1. Translational Research in Life Sciences -- Chapter 2. Preclinical disease models as a platform for drug discovery -- Chapter 3. Novel antibodies as a replacement for antibiotics -- Chapter 4. Functional Food and Nutraceuticals -- Chapter 5. Bio-Green-Technology as a multi-disciplinary interface amongst the Life Sciences. 330 $aThe present book addresses the multi-disciplinary nature of Translational Outcomes Research, which is a watershed for nearly all the disciplines of Life and Health Sciences, along with the Materials Sciences including but not limited to Zoology, Botany, Microbiology, Biochemistry, Physiology, Nanotechnology, the Medical Sciences, Bioengineering, Biophysics, Medicinal Chemistry, Structural Biology, Biostatistics and Bioinformatics. This book, for the first time, addresses the basic premises of fundamental research in facilitating drug discovery. One chapter is dedicated to a novel generation of platforms with novel camelid antibodies and their technological extensions, while another focuses on functional food and nutraceuticals. The book begins with a thorough overview of what translational outcomes research connotes and what the current status of research in the area is, and goes on to elucidate various pertinent preclinical disease models and their uses in basic and application based research in the Life Sciences. How basic approaches to screening and characterization vis-à-vis their role in amelioration of the two cardinal problems of inflammation and degeneration involved in most diseases is elucidated. The book ends with a discussion of the relevance and importance of using Bio Green technology in Translational Outcomes, addressing the need to fill the gap between academia and industry and clinics that can arise through direct or indirect collaboration between the stakeholders and emphasizing the need for an eco-friendly approach so as not to jeopardize the fine balance that holds life on earth in harmony. 606 $aRegenerative medicine 606 $aTissue engineering 606 $aMolecular biology 606 $aGene therapy 606 $aImmunoglobulins 606 $aAnimal models in research 606 $aRegenerative Medicine/Tissue Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/L16080 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aGene Therapy$3https://scigraph.springernature.com/ontologies/product-market-codes/B12020 606 $aAntibodies$3https://scigraph.springernature.com/ontologies/product-market-codes/B14010 606 $aAnimal Models$3https://scigraph.springernature.com/ontologies/product-market-codes/L25050 615 0$aRegenerative medicine. 615 0$aTissue engineering. 615 0$aMolecular biology. 615 0$aGene therapy. 615 0$aImmunoglobulins. 615 0$aAnimal models in research. 615 14$aRegenerative Medicine/Tissue Engineering. 615 24$aMolecular Medicine. 615 24$aGene Therapy. 615 24$aAntibodies. 615 24$aAnimal Models. 676 $a612.028 676 $a571.538 700 $aBanerjee$b Ena Ray$4aut$4http://id.loc.gov/vocabulary/relators/aut$0973671 906 $aBOOK 912 $a9910253867703321 996 $aPerspectives in Translational Research in Life Sciences and Biomedicine$92215706 997 $aUNINA